Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Arthritis Research and Therapy Year : 2005

Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.

Abstract

We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of nifedipine on superoxide anion (O2*-) production by peripheral blood monocytes. We compared 10 healthy controls with 12 patients with SSc, first after interruption of treatment with DTCCA and second after 2 weeks of treatment with nifedipine (60 mg/day). O2*- production by monocytes stimulated with phorbol myristate acetate (PMA) was quantified by the cytochrome c reduction method. We also investigated the effects in vitro of DTCCA on O2*- production and protein phosphorylation in healthy monocytes and on protein kinase C (PKC) activity using recombinant PKC. After DTCCA had been washed out, monocytes from patients with SSc produced more O2*- than those from controls. Nifedipine treatment considerably decreased O2*- production by PMA-stimulated monocytes. Treatment of healthy monocytes with nifedipine in vitro inhibited PMA-induced O2*- production and protein phosphorylation in a dose-dependent manner. Finally, nifedipine strongly inhibited the activity of recombinant PKC in vitro. Thus, the oxidative stress damage observed in SSc is consistent with O2*- overproduction by primed monocytes. This was decreased by nifedipine treatment both in vivo and in vitro. This beneficial property of nifedipine seems to be mediated by its cellular action and by the inhibition of PKC activity. This supports the hypothesis that this drug could be useful for the treatment of diseases associated with oxidative stress.
Fichier principal
Vignette du fichier
ar1457.pdf (336.75 Ko) Télécharger le fichier
Loading...

Dates and versions

inserm-00096184 , version 1 (19-09-2006)

Identifiers

Cite

Yannick Allanore, Didier Borderie, Axel Périanin, Hervé Lemaréchal, Ohvanesse Garabed Ekindjian, et al.. Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.. Arthritis Research and Therapy, 2005, 7, pp.R93-100. ⟨10.1186/ar1457⟩. ⟨inserm-00096184⟩
175 View
35091 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More